Global Influenza Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast

October 2016 | 106 pages | ID: GF3F0B3E4ECEN
Value Market Research

Abstracts

The report on global influenza diagnostics market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2015-2022. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

Drivers

• Rising geriatric population
• Growing prevalence of chronic diseases
• Increasing government initiatives to counter influenza
• Emergence of technologically advanced influenza diagnostics tests

Restraints

Product safety and high cost of development

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

Base Year: 2015

Estimated Year: 2016

Forecast Till: 2022

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on test type and end-use. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

Leading Segment in this market:

• By Test Type - RIDT
• By End-Use - Hospitals
• By Geography - North America

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Becton, Dickinson and Company, Quidel Corporation, Roche, Sekisui Diagnostics, LLC, SA Scientific Ltd., Meridian Bioscience, Inc., Thermo Fisher Scientific, 3M Health Care, and Alere. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Test Type:

• RIDT
• RT-PCR
• Cell Culture
• Others

By End-Use:

• Hospitals
• POCT
• Laboratories

By Geography:

• North America (NA)
• Europe (EU)
• Asia Pacific (APAC)
• Latin America (LA)
• Middle East & Africa (MEA)

Contents

1. INTRODUCTION TO THE INFLUENZA DIAGNOSTICS MARKET

1.1. Report Description
  1.1.1. Objectives Of The Study
  1.1.2. Assumptions
1.2. Research Scope
1.3. Research Methodology
  1.3.1. Top-Down Approach
  1.3.2. Bottom-Up Approach
  1.3.3. Data Sources
  1.3.4. Stakeholders

2. EXECUTIVE SUMMARY

3. MARKET ANALYSIS OF INFLUENZA DIAGNOSTICS

3.1. Introduction
3.2. Value Chain Analysis
3.3. Drivers
3.4. Restraints
3.5. Opportunities
3.6. Porter’s Five Forces Analysis

4. GLOBAL INFLUENZA DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

4.1. Influenza Diagnostics Market By Test Type
4.2. Influenza Diagnostics Market In RIDT
4.3. Influenza Diagnostics Market In RT-PCR
4.4. Influenza Diagnostics Market In Cell Culture
4.5. Influenza Diagnostics Market In Others

5. GLOBAL INFLUENZA DIAGNOSTICS MARKET ANALYSIS BY END-USE

5.1. Influenza Diagnostics Market By End-Use
5.2. Influenza Diagnostics Market In Hospitals
5.3. Influenza Diagnostics Market In POCT
5.4. Influenza Diagnostics Market In Laboratories

6. GLOBAL INFLUENZA DIAGNOSTICS MARKET ANALYSIS BY REGION

6.1. Regional Outlook
6.2. Introduction
6.3. North America (NA)
  6.3.1. North America: Influenza Diagnostics Market Estimates
  6.3.2. North America: Influenza Diagnostics Market Estimates By Country
  6.3.3. United States (U.S.)
  6.3.4. Rest Of North America
6.4. Europe (EU)
  6.4.1. Europe: Influenza Diagnostics Market Estimates
  6.4.2. Europe: Influenza Diagnostics Market Estimates By Country
  6.4.3. United Kingdom
  6.4.4. Germany
  6.4.5. France
  6.4.6. Rest Of Europe
6.5. Asia Pacific (APAC)
  6.5.1. Asia Pacific: Influenza Diagnostics Market Estimates
  6.5.2. Asia Pacific: Influenza Diagnostics Market Estimates By Country
  6.5.3. China
  6.5.4. Japan
  6.5.5. India
  6.5.6. Rest Of Asia Pacific
6.6. Latin America (LA)
  6.6.1. Latin America: Influenza Diagnostics Market Estimates
  6.6.2. Latin America: Influenza Diagnostics Market Estimates By Country
  6.6.3. Brazil
  6.6.4. Rest Of Latin America
6.7. Middle East And Africa (MEA)
  6.7.1. Middle East And Africa: Influenza Diagnostics Market Estimates
  6.7.2. Middle East And Africa: Influenza Diagnostics Market Estimates By Country
  6.7.3. Middle East
  6.7.4. Africa

7. COMPETITIVE LANDSCAPE OF THE INFLUENZA DIAGNOSTICS COMPANIES

7.1. Influenza Diagnostics Market Competition
7.2. Partnership/Collaboration/Agreements
7.3. Mergers And Acquisitions
7.4. New Product Development
7.5. Other Developments

8. COMPANY PROFILES OF INFLUENZA DIAGNOSTICS INDUSTRY

8.1. 3M Health Care
8.2. Alere Inc.
8.3. Becton, Dickinson and Company
8.4. Meridian Bioscience, Inc.
8.5. Quidel Corporation
8.6. Roche Holding AG
8.7. SA Scientific Ltd.
8.8. Sekisui Diagnostics, LLC
8.9. Thermo Fisher Scientific